Elanco Animal Health (ELAN) Cost of Revenue (2017 - 2026)
Elanco Animal Health (ELAN) posted Cost of Revenue of $586.0 million for Q1 2026, up 5.59% sequentially from $555.0 million in Q4 2025, and up 15.13% YoY from $509.0 million in Q1 2025.
Elanco Animal Health (ELAN) Cost of Revenue (2017 - 2026) Analysis & Trends
Elanco Animal Health has reported Cost of Revenue for 10 years, with the latest figure at $586.0 million in Q1 2026.
- Quarterly Cost of Revenue rose 15.13% year-over-year to $586.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.2 billion (up 10.12% YoY) and the FY2025 annual result came in at $2.1 billion, up 5.94% from the prior year.
- Cost of Revenue rose to $586.0 million in Q1 2026 per ELAN's latest filing, from $555.0 million in the prior quarter.
- Over five years, Cost of Revenue peaked at $586.0 million in Q1 2026 and troughed at $434.0 million in Q2 2023.
- A 5-year average of $503.2 million and a median of $501.0 million in 2024 frame the typical range for Cost of Revenue.
- The sharpest annual moves came in 2022 and 2023: Cost of Revenue retreated 12.16% in 2022, then grew 15.18% in 2023.
- Over 5 years, Cost of Revenue stood at $448.0 million in 2022, then advanced by 15.18% to $516.0 million in 2023, then declined by 2.91% to $501.0 million in 2024, then increased by 10.78% to $555.0 million in 2025, then gained by 5.59% to $586.0 million in 2026.
- According to Business Quant data, Cost of Revenue over the past three periods registered $586.0 million, $555.0 million, and $530.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.81 Bn | 42.84 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.29 Bn | 39.63 Bn | 2.15 Bn | 1.99 Bn |
| 3 | Zoetis | 31.59 Bn | 29.91 Bn | 1.05 Bn | 673.00 Mn |
| 4 | Takeda Pharmaceutical | 28.67 Bn | 22.88 Bn | 5.10 Bn | 2.55 Bn |
| 5 | United Therapeutics | 22.24 Bn | 19.58 Bn | 683.80 Mn | 99.50 Mn |
| 6 | Viatris | 18.79 Bn | 17.91 Bn | 1.46 Bn | 2.30 Bn |
| 7 | Neurocrine Biosciences | 15.71 Bn | 15.32 Bn | 935.80 Mn | 23.20 Mn |
| 8 | Elanco Animal Health | 12.09 Bn | 11.56 Bn | 798.00 Mn | 570.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Alkermes | 8.19 Bn | 7.53 Bn | 397.90 Mn | 98.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 570.00 Mn |
| Jun 30, 2026 | 570.00 Mn |
| Mar 31, 2026 | 586.00 Mn |
| Mar 31, 2026 | 586.00 Mn |
| Dec 31, 2025 | 555.00 Mn |
| Dec 31, 2025 | 555.00 Mn |
| Sep 30, 2025 | 530.00 Mn |
| Sep 30, 2025 | 530.00 Mn |
| Jun 30, 2025 | 528.00 Mn |
| Jun 30, 2025 | 528.00 Mn |
| Mar 31, 2025 | 509.00 Mn |
| Mar 31, 2025 | 509.00 Mn |
| Dec 31, 2024 | 501.00 Mn |
| Dec 31, 2024 | 501.00 Mn |
| Sep 30, 2024 | 492.00 Mn |
| Sep 30, 2024 | 492.00 Mn |
| Jun 30, 2024 | 495.00 Mn |
| Jun 30, 2024 | 495.00 Mn |
| Mar 31, 2024 | 515.00 Mn |
| Mar 31, 2024 | 515.00 Mn |